Weller, Michael

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

van den Bent, M. J., French, P. J., Brat, D., Tonn, J. C., Touat, M., Ellingson, B. M., Young, R. J., Pallud, J., von Deimling, A., Sahm, F., et al. (2024) · Neuro-Oncology

Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 88

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

Tesileanu, C. M. S., Vallentgoed, W. R., Sanson, M., Taal, W., Clement, P. M., Wick, W., Brandes, A. A., Baurain, J. F., Chinot, O. L., Wheeler, H., et al. (2021) · Acta Neuropathologica

Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 62

A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498.

Sampson, J. H., Omuro, A. M. P., Preusser, M., Lim, M., Butowski, N. A., Cloughesy, T. F., Strauss, L. C., Latek, R. R., Paliwal, P., Weller, M., et al. (2016) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 53

Identification of inhibitor‐of‐differentiation 2 (Id2) as a modulator of neuronal apoptosis

Gleichmann, M., Buchheim, G., El‐Bizri, H., Yokota, Y., Klockgether, T., Kügler, S., Bähr, M., Weller, M., & Schulz, J. B. (2002) · Journal of Neurochemistry

Cell death mechanisms and regulationNeurogenesis and neuroplasticity mechanisms

Cited by 35

Very‐late‐onset adrenoleukodystrophy: Possible precipitation of demyelination by cerebral contusion

Weller, M., Liedtke, W., Petersen, D., Opitz, H., & Poremba, M. (1992) · Neurology

Metabolism and Genetic DisordersLysosomal Storage Disorders Research

Cited by 33

Genetic variants of methionine metabolism and X-ALD phenotype generation: Results of a new study sample

Semmler, A., Bao, X., Cao, G., Köhler, W., Weller, M., Aubourg, P., & Linnebank, M. (2009) · Journal of Neurology

Metabolism and Genetic DisordersLysosomal Storage Disorders Research

Cited by 30

Prevalence of potential sports‐associated risk factors in Swiss amyotrophic lateral sclerosis patients

Feddermann‐Demont, N., Junge, A., Weber, K. P., Weller, M., Dvořák, J., & Tarnutzer, A. A. (2017) · Brain and Behavior

Amyotrophic Lateral Sclerosis ResearchTraumatic Brain Injury Research

Cited by 29

Supraagonistic, bispecific single‐chain antibody purified from the serum of cloned, transgenic cows induces T‐cell‐mediated killing of glioblastoma cells in vitro and in vivo

Grosse‐Hovest, L., Wick, W., Minoia, R., Weller, M., Rammensee, H., Brem, G., & Jung, G. (2005) · International Journal of Cancer

Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses

Cited by 23